Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Classement en actions #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Prix de l'action
$0.71707249
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$94.14M
Changement (1 jour)
-3.31%
Changement (1 an)
76.82%
Pays
SE
Échange AlzeCure Pharma AB (ALZCUR)

Catégorie

EPS pour AlzeCure Pharma AB (ALZCUR)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de AlzeCure Pharma AB, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de AlzeCure Pharma AB de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH